EFFECT OF A PRACTICE-WIDE ANTI-TNF THERAPEUTIC DRUG MONITORING PROGRAM ON OUTCOMES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Lyles, John L.
Mulgund, Aditi A.
Bauman, Laura E.
Su, Weizhe
Fei, Lin
Chona, Deepika
Sharma, Puneet
Etter, Renee
Hellmann, Jennifer
Denson, Lee A.
Minar, Phillip P.
Dykes, Dana M.
Rosen, Michael J.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
303
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease
    Lyles, John L.
    Mulgund, Aditi A.
    Bauman, Laura E.
    Su, Weizhe
    Fei, Lin
    Chona, Deepika L.
    Sharma, Puneet
    Etter, Renee K.
    Hellmann, Jennifer
    Denson, Lee A.
    Minar, Phillip
    Dykes, Dana M.
    Rosen, Michael J.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (04) : 482 - 492
  • [2] Effect of an Anti-TNF Therapeutic Drug Monitoring Quality Improvement Program on Inflammatory Bowel Disease Patient Outcomes at a Large Academic Pediatric Gastroenterology Practice
    Mulgund, Aditi A.
    Bauman, Laura
    Chona, Deepika L.
    Sharma, Puneet
    Su, Weizhe
    Fei, Lin
    Denson, Lee A.
    Minar, Phillip
    Dykes, Dana M.
    Rosen, Michael J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S402 - S403
  • [3] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [4] Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease
    Franca, Raffaella
    Curci, Debora
    Lucafo, Marianna
    Decorti, Giuliana
    Stocco, Gabriele
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (07) : 527 - 539
  • [5] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [6] Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
    Eun, Chang Soo
    GUT AND LIVER, 2017, 11 (01) : 3 - 4
  • [7] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309
  • [8] Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease
    Baert, Filip
    DIGESTIVE DISEASES, 2015, 33 : 70 - 77
  • [9] Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S235 - S236
  • [10] Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
    Samaan, Mark A.
    Arkir, Zehra
    Ahmad, Tariq
    Irving, Peter M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (12) : 1271 - 1279
12345